Harmony Biosciences Holdings Inc HRMY Compte de résultat

Quarter End	Déc 2022	Mar 2023	Juin 2023	Sept 2023	Déc 2023	Mar 2024	Juin 2024	Sept 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Revenu total	128,31M	119,13M	134,22M	160,27M	168,41M	154,62M	172,81M	186,04M
Revenu d'exploitation	47,61M	40,42M	46,9M	64,36M	40,2M	52,03M	21,36M	61,71M
Revenu avant impôt	44,1M	37,78M	44,1M	51,83M	39,69M	51,79M	21,69M	62,17M
Revenu net	48,51M	29,49M	34,3M	38,46M	26,61M	38,33M	11,36M	46,83M
Dividendes privilégiés	0	0	0	0	0	0	0	0
Résultat de base par action	0	0	0	0	0	0	0	0
EBIT	47,69M	40,43M	46,87M	64,36M	40,36M	51,89M	21,39M	61,59M
EBITDA	53,68M	46,49M	52,97M	70,47M	46,32M	58,16M	27,41M	67,68M

Fin d'année 31 Décembre 2023	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Revenu total	0	6M	159,74M	305,44M	437,86M	582,02M
Revenu d'exploitation	-41,44M	-145,9M	16,99M	87,53M	120,19M	192,03M
Revenu avant impôt	-39,9M	-151,98M	-36,94M	37,43M	104,69M	173,4M
Revenu net	-70,08M	-187,21M	-63,85M	34,6M	181,47M	128,85M
Dividendes privilégiés	-30,19M	-35,23M	-26,9M	0	0	0
Résultat de base par action	-0.233	-0.574	-0.17	0.092	0.48	0.342
EBIT	-41,44M	-145,9M	-8,72M	87,54M	120,36M	192,19M
EBITDA	-41,26M	-142,69M	27,22M	106,37M	143,57M	216,39M